Abstract:N 6 -methyladenosine (m 6 A) is a prevalent RNA modification that plays a key role in regulating eukaryotic cellular mRNA functions. RNA m 6 A modification is regulated by two groups of cellular proteins, writers and erasers that add or remove m 6 A, respectively. HIV-1 RNA contains m 6 A modifications that modulate viral infection and gene expression in CD4 + T cells. However, it remains unclear whether m 6 A modifications of HIV-1 RNA modulate innate immune responses in myeloid cells that are important for antiviral immunity. Here we show that m 6 A modification of HIV-1 RNA suppresses the expression of antiviral cytokine type-I interferon (IFN-I) in differentiated human monocytic cells and primary monocyte-derived macrophages. Transfection of differentiated monocytic U937 cells with HIV-1 RNA fragments containing a single m 6 A-modification significantly reduced IFN-I mRNA expression relative to their unmodified RNA counterparts. We generated HIV-1 with altered m 6 A levels of RNA by manipulating the expression of the m 6 A erasers (FTO and ALKBH5) or pharmacological inhibition of m 6 A addition in virus-producing cells, or by treating HIV-1 RNA with recombinant FTO in vitro . HIV-1 RNA transfection or viral infection of differentiated U937 cells and primary macrophages demonstrated that HIV-1 RNA with decreased m 6 A levels enhanced IFN-I expression, whereas HIV-1 RNA with increased m 6 A modifications had opposite effects. Our mechanistic studies indicated that m 6 A of HIV-1 RNA escaped retinoic acid-induced gene I (RIG-I)-mediated RNA sensing and activation of the transcription factors IRF3 and IRF7 that drive IFN-I gene expression. Together, these findings suggest that m 6 A modifications of HIV-1 RNA evade innate immune sensing in myeloid cells.

N6-methyladenosine modification is not a general trait of viral RNA genomes

N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Elucidation of the Epitranscriptomic RNA Modification Landscape of Chikungunya Virus

The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses

N6-methyladenosine modification—a key player in viral infection

N6-Methyldeoxyadenosine Marks Active Transcription Start Sites in Chlamydomonas

Analysis of N6-Methyladenosine Modification of HBV RNA by Methylated RNA Immunoprecipitation

Challenges to mapping and defining m6A function in viral RNA

N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I

Characterization of m6A modifications in the contemporary Zika virus genome and host cellular transcripts

N6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling

Recent insights into N 6 -methyladenosine during viral infection

N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages

No evidence for epitranscriptomic m5C modification of SARS-CoV-2, HIV and MLV viral RNA

N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA

Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA

Decoding epitranscriptomic regulation of viral infection: mapping of RNA N6-methyladenosine by advanced sequencing technologies

m6A Reader Proteins: The Executive Factors in Modulating Viral Replication and Host Immune Response

The dynamics of N6-methyladenine RNA modification in interactions between rice and plant viruses

The Roles of N6-Methyladenosine Modification in Plant-RNA Virus Interactions